Skip to content

Methods to increase formation of a photosentisizer in the skin of healthy volunteers

Methods to increase PpIX formation in the skin of healthy volunteers

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
EU CTR
Registry ID
EUCTR2014-001440-38-DK
Enrollment
Unknown
Registered
2014-04-11
Start date
2014-05-22
Completion date
Unknown
Last updated
2015-12-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Healthy volunteers - no medical condition is investigated but pharmaco kinetics MedDRA version: 17.0 Level: HLGT Classification code 10040879 Term: Skin investigations System Organ Class: 10022891 - Investigations

Interventions

Sponsors

Department of Dermatology D92, Bispebjerg Hospital
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: Healthy volunteers 18 years or older informed and written consent Fertile women have to use safe contraceptive measures Medical record with regards to medical treatment is mandatory before inclusion Are the trial subjects under 18? no Number of subjects for this age range: F.1.2 Adults (18-64 years) yes F.1.2.1 Number of subjects for this age range 15 F.1.3 Elderly (>=65 years) yes F.1.3.1 Number of subjects for this age range 15

Exclusion criteria

Exclusion criteria: Allergy to the creams and ointments used in the trial Relevant active skin disease in treatment area Pregnancy or breastfeeding Concurrent participation in other clinical trials

Design outcomes

Primary

MeasureTime frame
Main Objective: Measure formation of PpIX in healthy volunteers over a period of 24 hours. In addition establish if pre treatment with curettage or two ointments used to treat psoriasis have an effect on PpIX formation;Secondary Objective: Not applicable;Primary end point(s): Amount of PpIX formed over a period of 24 hours;Timepoint(s) of evaluation of this end point: Hourly for 5 hours and after 18, 21, 24 hours

Secondary

MeasureTime frame
Secondary end point(s): N/A;Timepoint(s) of evaluation of this end point: N/A

Countries

Denmark

Contacts

Public ContactDepartment of Dermatology D92,

Bispebjerg Hospital

hans.christian.olsen.wulf@regionh.dk

Outcome results

None listed

Source: EU CTR (via WHO ICTRP) · Data processed: Feb 4, 2026